KBLB Kraig Biocraft Laboratories Inc.

Kraig Biocraft Laboratories takes Measures to Support Furloughed Staff and Their Communities

Kraig Biocraft Laboratories takes Measures to Support Furloughed Staff and Their Communities

ANN ARBOR, Mich., April 13, 2020 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB), the leading developer of spider silk based fibers, announces that Kim Thompson, the Company’s CEO and Founder, and Kenneth Le, the President of Prodigy Textiles, will be making a personal donation, on behalf of all Kraig and Prodigy Employees, to the community of Quang Nam Province Vietnam.  Quang Nam is where the Company maintains a production facility and where most of the employees of Prodigy, Kraig’s wholly owned subsidiary, reside. The financial gift is being made in light of the global financial and public health issues facing our world. 

Through this donation, direct food aid will be provided to roughly 600 families in the farming cooperatives and villages in Quang Nam.  Each family will receive 10kg of rice, noodles, cooking oil, fish sauce, and other items.  Additional financial aid being provided will be coordinated by Mr. Le, in partnership with local officials, to ensure that other critical needs in the community are met.

In mid-March the Company took the voluntary step to furlough non-essential workers, as a precautionary step.  To minimize the financial impact of this decision, on furloughed staff, Company management has committed to keep these workers on the payroll through at least the end of April.  Today’s announcement is a further expansion of the Company’s commitment to our team members and their communities.

“I am thankful for the opportunity to personally support our valued team members,” said Thompson.  “As we all work together to combat coronavirus, our team at Kraig Labs continues to make significant progress in critical aspects of our business model.  Having laid a solid foundation, our teams in the US and Vietnam are preparing the Company to exit this stronger than ever.   I believe that this will be a break out year for Kraig Labs, so the least our management team can do is share a little of that good fortune and spread it forward to the communities that are our home.  I want to thank Mr. Ken Le for his generosity, his bold vision and his friendship.  These monies will not come from the corporate treasury.”

“Later this week we will be revealing a major research and development milestone from within our own laboratories,” continued Thompson.  “We view this breakthrough as the most significant and impactful development in our laboratories in more than seven years.  Our scientists are working tirelessly in our pursuit of commercializing nature’s toughest fibers, spider silk. I encourage those who are interested to join us for this live event.”

On April 16 at 4:30pm ET, the Company will be revealing a significant scientific breakthrough in spider silk technology during an online press conference.  All interested parties can view this live event by going to

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to .

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

 

EN
13/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kraig Biocraft Laboratories Inc.

 PRESS RELEASE

From Lab Fiber to Luxury Fabric: Kraig Biocraft Laboratories Targets A...

From Lab Fiber to Luxury Fabric: Kraig Biocraft Laboratories Targets Apparel First with Engineered Spider Silk DENVER, April 02, 2026 (GLOBE NEWSWIRE) -- () -- Kraig Biocraft Laboratories (OTCQB: KBLB) is advancing a transgenic silkworm platform designed to produce recombinant spider silk at commercial scale, positioning the company at the intersection of genetic engineering, materials science, and textile manufacturing. Spider silk has long been studied for its combination of strength, elasticity, and low weight. The challenge has been producing it economically at scale. Kraig’s approac...

 PRESS RELEASE

Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Productio...

Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Production Hybrids, Achieving Key Milestone in its Aggressive Scale-Up Plan ANN ARBOR, Mich., March 30, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced the successful deployment of more than 700,000 BAM-1 Alpha production hybrids of its previously reported 1,000,000 egg inventory. These silkworms are now in active production. This achievement underscores the Company's continued execution of its previou...

 PRESS RELEASE

Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas B...

Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas Breakthroughs Creating New Spider Silk Transgenics ANN ARBOR, Mich., March 23, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced a significant expansion of its research and development capacity designed to keep pace with rapid progress of its advanced materials initiative, Project Atlas. The Company has expanded its laboratory capabilities, onboarding new scientific personnel and the deploymen...

 PRESS RELEASE

Engineered Silkworms Spin Spider Silk as Biotech Firm Targets Commerci...

Engineered Silkworms Spin Spider Silk as Biotech Firm Targets Commercial Scale DENVER, March 18, 2026 (GLOBE NEWSWIRE) --  -- A biotechnology company developing genetically engineered silkworms says it’s moving toward commercial production of spider silk, a material long sought by researchers for its unusual combination of strength and elasticity. Kraig Biocraft Laboratories (OTCQB: KBLB) deployed one million genetically engineered silkworm eggs across multiple production facilities in Vietnam as part of a Spring scale-up effort that could eventually produce around 10 metric tons of reco...

 PRESS RELEASE

24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the Making

24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the Making DENVER, March 11, 2026 (GLOBE NEWSWIRE) -- -- In technology and biotechnology, “unicorn” status is typically reserved for private companies valued at $1 billion or more; often backed by major venture rounds, institutional syndicates, and aggressive capital deployment strategies. But what happens when a company advances a platform with billion-dollar potential without the backing of Silicon Valley mega-funding? That question is increasingly being asked about Kraig Biocraft Laboratories (OTCQB: KBLB). More than a decade ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch